Genstar Capital completes acquisition of PRA

San Francisco-based private equity firm Genstar Capital LLC has completed its $797 milion acquisition of PRA International, a global clinical research organization based in North Carolina, the company announced today.

Shareholders approved the acquisition Wednesday and will receive $30.50 per share of common stock in cash. PRA stock will be delisted from Nasdaq at the close of the  markets.

How do you remember Stephen Sondheim?

Bay Area artists celebrate and mourn reinventor of American musical

By Janos Gereben
After mob thefts, Black Friday offers glimmers of hope for retailers

Shoppers hunted for deals amidst heightened security

By Sydney Johnson